List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 492 studies with search of:   Australia, South Australia
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
Conditions: Atrial Fibrillation;   Atrial Flutter
Interventions: Drug: warfarin;   Drug: apixaban
2 Active, not recruiting Comparative Study of Laparoscopic Versus Open Operations for Colon Cancer
Condition: Colonic Neoplasms
Interventions: Procedure: Laparoscopic-assisted colectomy;   Procedure: Conventional open colectomy
3 Completed ASTERIX: Low Dose ASA and Nexium
Condition: Gastroesophageal Reflux
Intervention: Drug: Esomeprazole
4 Active, not recruiting Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: CHOP regimen;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: prednisone;   Drug: rituximab;   Drug: vincristine sulfate
5 Recruiting A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects
Condition: Acute Coronary Syndrome
Interventions: Drug: Clopidogrel;   Drug: Prasugrel;   Drug: Commercially-available Aspirin
6 Completed Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
Condition: Cardiovascular Diseases
Interventions: Drug: Telmisartan;   Drug: Combination of Telmisartan and Ramipril;   Drug: Ramipril
7 Completed RE-MODEL Dabigatran Etexilate 150mg or 220mg o.d vs. Enoxaparin 40mg o.d for Prevention of Thrombosis After Knee Surgery
Conditions: Arthroplasty, Replacement, Knee;   Thromboembolism
Interventions: Drug: "Dabigatran etexilate (oral, 150 mg once daily)";   Drug: "Enoxaparin (subcutaneous, 40 mg once daily)";   Drug: "Dabigatran etexilate (oral, 220 mg once daily)"
8 Completed Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
Conditions: Bowel Dysfunction;   Constipation
Intervention: Drug: alvimopan
9 Completed Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
Conditions: Bowel Dysfunction;   Constipation
Intervention: Drug: alvimopan
10 Completed Postmenopausal Evaluation and Risk-Reduction With Lasofoxifene (PEARL)
Condition: Osteoporosis
Interventions: Drug: lasofoxifene;   Other: placebo;   Drug: lasofoxifene
11 Recruiting A Randomised, Open-Label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-Emtricitabine or Abacavir-Lamivudine: The STEAL Study
Condition: HIV Infections
Interventions: Drug: Emtricitabine 200mg – Tenofovir 300mg;   Drug: Abacavir 600mg – Lamivudine 300mg
12 Recruiting A Study of Galiximab + Rituximab Versus Rituximab + Placebo in Follicular Non-Hodgkin's Lymphoma (NHL)
Condition: Lymphoma, Non-Hodgkin's
Interventions: Drug: Galiximab in combination with rituximab;   Drug: Rituximab in combination with placebo
13 Completed Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI)
Condition: Acute Myocardial Infarction
Interventions: Drug: Pexelizumab;   Drug: Placebo infusion
14 Completed Safety and Efficacy of Bronchitol in Bronchiectasis
Condition: Bronchiectasis
Interventions: Drug: Mannitol;   Drug: placebo
15 Active, not recruiting Gemcitabine With or Without Erlotinib in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: erlotinib hydrochloride;   Drug: gemcitabine hydrochloride
16 Enrolling by invitation Retreatment Study of Galiximab + Rituximab in Follicular Non-Hodgkin's Lymphoma (NHL)
Condition: Non-Hodgkin Lymphoma
Intervention: Drug: galiximab in combination with rituximab
17 Completed The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Intervention: Drug: Mitomycin C; Capecitabine; Bevacizumab
18 Completed A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects With Acute Lung Injury
Conditions: Respiratory Distress Syndrome, Adult;   Acute Lung Injury
Intervention: Drug: Sivelestat
19 Terminated A Study Examining Torcetrapib/Atorvastatin And Atorvastatin Effects On Clinical CV Events In Patients With Heart Disease
Conditions: Coronary Disease;   Diabetes Mellitus
Interventions: Drug: torcetrapib/atorvastatin;   Drug: atorvastatin
20 Recruiting Lumiliximab With Fludarabine, Cyclophosphamide, and Rituximab (FCR) Versus FCR Alone in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL)
Condition: Chronic Lymphocytic Leukemia
Interventions: Drug: FCR + Lumiliximab;   Drug: FCR

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services